| Literature DB >> 32415136 |
Jeffrey C Chandler1, Jennifer E Anders2, Nicolas A Blouin3, James C Carlson1, Jeffrey T LeJeune4, Lawrence D Goodridge5, Baolin Wang2, Leslie A Day2, Anna M Mangan1, Dustin A Reid1, Shannon M Coleman6, Matthew W Hopken7, Bledar Bisha8.
Abstract
Antimicrobial use in livestock production is a driver for the development and proliferation of antimicrobial resistance (AMR). Wildlife interactions with livestock, acquiring associated AMR bacteria and genes, and wildlife's subsequent dispersal across the landscape are hypothesized to play an important role in the ecology of AMR. Here, we examined priority AMR phenotypes and genotypes of Escherichia coli isolated from the gastrointestinal tracts of European starlings (Sturnus vulgaris) found on concentrated animal feeding operations (CAFOs). European starlings may be present in high numbers on CAFOs (>100,000 birds), interact with urban environments, and can migrate distances exceeding 1,500 km in North America. In this study, 1,477 European starlings from 31 feedlots in five U.S. states were sampled for E. coli resistant to third generation cephalosporins (3G-C) and fluoroquinolones. The prevalence of 3G-C and fluoroquinolone-resistant E. coli was 4% and 10%, respectively. Multidrug resistance in the E. coli isolates collected (n = 236) was common, with the majority of isolates displaying resistance to six or more classes of antibiotics. Genetic analyses of a subset of these isolates identified 94 genes putatively contributing to AMR, including seven class A and C β-lactamases as well as mutations in gyrA and parC recognized to confer resistance to quinolones. Phylogenetic and subtyping assessments showed that highly similar isolates (≥99.4% shared core genome, ≥99.6% shared coding sequence) with priority AMR were found in birds on feedlots separated by distances exceeding 150 km, suggesting that European starlings could be involved in the interstate dissemination of priority AMR bacteria.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32415136 PMCID: PMC7229194 DOI: 10.1038/s41598-020-64544-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Extent and diversity of clinically significant AMR phenotypes in CTX- and CIP-selected E. coli isolates collected from European starlings on CAFOs. Percent of (a) CTX-selected and (b) CIP-selected E. coli isolates for resistance to 18 antibiotics. The number of antibiotics resisted by (c) CTX-selected and (d) CIP-selected E. coli isolates.
Number and type of AMR determinants predicted in 66 priority E. coli isolates collected from European starlings.
| Mechanism of action | # determinants |
|---|---|
| antibiotic efflux | 2256 |
| antibiotic efflux; antibiotic target alteration | 198 |
| antibiotic inactivation | 276 |
| antibiotic target alteration | 461 |
| antibiotic target alteration; antibiotic efflux | 5 |
| antibiotic target protection | 39 |
| antibiotic target replacement | 69 |
| reduced permeability to antibiotic; antibiotic efflux | 66 |
| reduced permeability to antibiotic; antibiotic efflux; antibiotic target alteration | 65 |
Figure 2In silico assessments of AMR genes found within 66 E. coli isolates collected from European starlings that were predicted to confer resistance to β-lactams. CARD-RGI analyses of isolates identified a total of 8 genes which putatively confer resistance to β-lactams. An additional 12 genes putatively involved in efflux of both β-lactams and quinolones were identified (see Supplementary Table 3). The column labeled ‘AMR’ represents phenotypic resistance characterization, and it is matched by row to the genotypic data presented in the left side columns. Cells shaded in white indicate that the gene was not present or the isolate was susceptible to the particular drug.
Figure 3In silico assessments of AMR genes found within 66 E. coli isolates collected from European starlings that were predicted to confer resistance to quinolones. CARD-RGI analyses of isolates identified 7 genes that putatively confer resistance to quinolones. An additional 12 genes putatively involved in efflux of both β-lactams and quinolones were identified (see Supplementary Table 3). The column labeled ‘AMR’ represents phenotypic resistance characterization, and it is matched by row to the genotypic data presented in the left side columns. Cells shaded in white indicate that the gene was not present or the isolate was susceptible to the particular drug.
Figure 4(a) Phylogenetic analysis of the core genomes of 66 E. coli isolates from European starlings. The color-coded outer ring shows the U.S. state in which the individual isolates were collected. Isolates are labelled by their sample ID #, predicted serotype, and location (state and CAFO ID). Colored stars marked at adjacent branches indicate isolate groups showing high sequence and coding region similarity (see Supplementary Table 4). (b) Map displaying an approximate location of CAFOs, and the proportion of all 236 CTX-resistant (yellow) or CIP-resistant (blue) E. coli isolates collected from these sites, with circle size proportionate to the total number of isolates collected from these sites.